Active Ingredient(s): Ferric Derisomaltose
FDA Approved: * January 16, 2020
Pharm Company: * PHARMACOSMOS AS
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Monoferric Overview

Ferric derisomaltose, sold under the brand name Monoferric, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).[1] It was approved for use in the United States in January 2020.[1][2][3] It is given intravenously.[1] References .mw-par...

Read more Monoferric Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Monoferric Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ferric Derisomaltose
  • Solution: 100mg/ml (100mg/ml), 1gm/10ml (100mg/ml), 500mg/5ml (100mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Monoferric: (3 results)

Sorted by National Drug Code
  • 49442-9301 Monoferric 100 mg/ml Intravenous Solution by Pharmacosmos A/S
  • 49442-9305 Monoferric 500 mg/5ml Intravenous Solution by Pharmacosmos A/S
  • 49442-9310 Monoferric 1000 mg/10ml Intravenous Solution by Pharmacosmos A/S

Other drugs which contain Ferric Derisomaltose or a similar ingredient: (1 result)